Trial
NCT01825369
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Heart Septal Defects, Ventricular
Intervention
IV L-carnitine
Why stopped
Changes to cardiac surgery program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-06